|
2,123
|
| 17407 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
Cystic fibrosis
|
|
| 17448 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
| 17449 |
P. aeruginosa infection, chronic
|
|
decreases_quantity of
|
flagellum
|
in patients with CF
|
| 17450 |
P. aeruginosa infection, chronic
|
|
decreases_quantity of
|
type IV pilus
|
in patients with CF
|
| 17833 |
P. aeruginosa infection, chronic
|
|
decreases_quantity of
|
SFTPA1
|
in patients with CF
|
| 17834 |
P. aeruginosa infection, chronic
|
|
decreases_quantity of
|
SFTPD
|
in patients with CF
|
|
15695491
|
Pseudomonas aeruginosa diseases
|
|
2,285
|
| 19608 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
2-Heptyl-3-hydroxy-4-quinolone, PQS
|
in sputum of CF patients
|
| 19609 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
2-Heptyl-4-quinolone, HHQ
|
in sputum of CF patients
|
| 19610 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
2-Heptyl-4-hydroxyquinoline N-oxide, HQNO
|
in sputum of CF patients
|
| 19611 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
2-Nonyl-4-hydroxyquinoline N-oxide, NQNO
|
in sputum of CF patients
|
| 19612 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
2-Undecyl-4-hydroxyquinoline N-oxide, UQNO
|
in sputum of CF patients
|
| 19613 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
phnA
|
in sputum of CF patients
|
| 19614 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
phnB
|
in sputum of CF patients
|
| 19615 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pqsA
|
in sputum of CF patients
|
| 19616 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pqsB
|
in sputum of CF patients
|
| 19618 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pqsC
|
in sputum of CF patients
|
| 19619 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pqsD
|
in sputum of CF patients
|
| 19621 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pqsE
|
in sputum of CF patients
|
|
20738404
|
Pseudomonas aeruginosa diseases
|
|
2,359
|
| 20784 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
psrA
|
in CF patients
|
|
19508282
|
Pseudomonas aeruginosa diseases
|
|
2,464
|
| 24081 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
T6SS-HSI-1
|
|
|
20947426
|
Pseudomonas aeruginosa diseases
|
|
2,524
|
| 23509 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
paaP
|
in CF isolates
|
|
19192306
|
Pseudomonas aeruginosa diseases
|
|
2,541
|
| 23646 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
azu
|
in sera of CF patients (from stationary-phase cultures)
|
| 23649 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
lasB
|
in sera of CF patients (from stationary-phase cultures)
|
| 23650 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
prpL
|
in sera of CF patients (from stationary-phase cultures)
|
| 23651 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
pasP
|
in sera of CF patients (from stationary-phase cultures)
|
|
18663005
|
Pseudomonas aeruginosa diseases
|
|
2,586
|
| 24372 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients witn CF
|
|
21833328
|
Pseudomonas aeruginosa diseases
|
|
2,592
|
| 24446 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
T6SS-HSI-1
|
in patients with CF
|
| 24456 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
biofilm formation
|
in patients with CF
|
| 24483 |
cdiGMP
|
|
increases_activity of
|
P. aeruginosa infection, chronic
|
if c-di-GMP level is high
|
|
21955777
|
Pseudomonas aeruginosa diseases
|
|
2,854
|
| 33965 |
gacS
|
|
affects_activity of
|
P. aeruginosa infection, chronic
|
|
| 33966 |
gacA
|
|
affects_activity of
|
P. aeruginosa infection, chronic
|
|
|
21515773
|
Pseudomonas aeruginosa diseases
|
|
2,906
|
| 26638 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL8
|
|
| 26644 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL1
|
|
| 26648 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL2
|
|
| 26651 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL3
|
|
| 26654 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
CXCL6
|
|
| 26657 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
ICAM1
|
|
| 26659 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
IL1A
|
|
| 26661 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
IL1B
|
|
| 26662 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
IL6
|
|
| 26667 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
TNF
|
|
| 26669 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
TLR2
|
|
| 26670 |
P. aeruginosa infection, chronic
|
|
decreases_expression of
|
TLR5
|
|
| 26673 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
NFKB1
|
|
| 26676 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
HBD-4
|
|
| 26677 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
DUOX1
|
|
| 26678 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
DUOX2
|
|
| 26679 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
inflammatory response
|
|
|
21659660
|
Pseudomonas aeruginosa diseases
|
|
2,932
|
| 26800 |
2-Amino acetophenone, 2-AA
|
|
increases_activity of
|
P. aeruginosa infection, chronic
|
|
|
21829370
|
Pseudomonas aeruginosa diseases
|
|
2,933
|
| 26820 |
2-Amino acetophenone, 2-AA
|
|
increases_activity of
|
P. aeruginosa infection, chronic
|
in flies
|
|
21829370
|
Pseudomonas aeruginosa diseases
|
|
3,151
|
| 29009 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
sialidase
|
in patients with cystic fibrosis
|
|
22309196
|
Pseudomonas aeruginosa diseases
|
|
3,183
|
| 29193 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
Pyocyanine
|
in CF patients
|
| 29206 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
MUC5B
|
in CF patients; the most abundant mucin in the sputum of CF
|
| 29213 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
MUC5AC
|
in CF patients
|
| 43315 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
mucus secretion
|
in CF patients
|
|
22103442
|
Pseudomonas aeruginosa diseases
|
|
3,202
|
| 29502 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
rsaL
|
in patients with CF
|
|
22354680
|
Pseudomonas aeruginosa diseases
|
|
3,220
|
| 29737 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
small colony variants, SCVs
|
|
|
20088866
|
Pseudomonas aeruginosa diseases
|
|
3,226
|
| 29760 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
| 29761 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
small colony variants, SCVs
|
in patients with CF
|
|
20300602
|
Pseudomonas aeruginosa diseases
|
|
3,233
|
| 29828 |
P. aeruginosa infection, chronic
|
|
decreases_activity of
|
mexAB-oprM multidrug efflux complex
|
|
|
21205015
|
Pseudomonas aeruginosa diseases
|
|
3,371
|
| 31007 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
mucoid strain
|
in patients with CF
|
|
21991261
|
Pseudomonas aeruginosa diseases
|
|
3,577
|
| 33497 |
aaaA
|
|
increases_activity of
|
P. aeruginosa infection, chronic
|
2 days and 8 days post infection
|
|
22927813
|
Pseudomonas aeruginosa diseases
|
|
3,827
|
| 38425 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
mucA-mut
|
|
|
22497280
|
Pseudomonas aeruginosa diseases
|
|
4,232
|
| 43266 |
P. aeruginosa infection, chronic
|
|
increases_quantity of
|
magD
|
|
|
23919994
|
Pseudomonas aeruginosa diseases
|
|
4,337
|
| 44355 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pvdS
|
in sputum of most but not all CF patients
|
| 44369 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pvdH
|
in sputum of most but not all CF patients
|
| 44370 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pvdL
|
in sputum of most but not all CF patients
|
| 44372 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
pchF
|
in sputum of most but not all CF patients
|
| 44381 |
P. aeruginosa infection, chronic
|
|
affects_quantity of
|
Pyoverdine I
|
in sputum of most but not all CF patients
|
| 44384 |
P. aeruginosa infection, chronic
|
|
affects_quantity of
|
Pyochelin
|
in sputum of most but not all CF patients
|
| 44395 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
heme uptake system, Has
|
in sputum of most but not all CF patients
|
| 44396 |
P. aeruginosa infection, chronic
|
|
increases_activity of
|
heme uptake system, Phu
|
in sputum of most but not all CF patients
|
| 44397 |
P. aeruginosa infection, chronic
|
|
increases_expression of
|
feoB
|
in sputum of all CF patients
|
|
23690396
|
Pseudomonas aeruginosa diseases
|
HoPaCI